Analysts think BSGM stock price could increase by 653%
Sep 26, 2024, 11:25 AM
156.50%
What does BSGM do
BioSig Technologies, based in Westport, Connecticut, develops the PURE EP Platform, a non-invasive device that enhances electrocardiographic signals to improve cardiac ablation procedures. The company went public on September 22, 2014, and employs four people.
3 analysts think BSGM stock price will increase by 653.10%. The current median analyst target is $2.55 compared to a current stock price of $0.34. The lowest analysts target is $2.52 and the highest analyst target is $2.63.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
